You are now viewing our public site. Back to Dashboard

Childhood Motor Speech Disorders: Neuroplasticity and LSVT LOUD

presented by Cynthia M. Fox, PhD, CCC-SLP

Accrediting Body:

Target Audience:

Levels:
Disclosure Statement:

This course was developed in conjunction with LSVT Global, Inc. LSVT Global, Inc receives compensation from MedBridge for this course.

The LSVT LOUD was developed and patented as a licensed technology trademarked as the LSVT LOUD®. Because there are no other similar products available, this course will only cover information that pertains to the effective and safe use of the above-named product(s).

This presentation will focus exclusively on and will not include information other similar or related products.

Financial: Cynthia Fox is an employee and Cofounder of LSVT Global, Inc. She received a lecture honorarium from LSVT Global, Inc. and has financial interest in the company. There is no financial interest beyond the production of this course.

Non-Financial: Cynthia Fox has preference for the LSVT protocols as treatment techniques, which will be discussed as a part of this course.

Financial: Carol Boliek is an independent consultant and LSVT BIG® Training and Certification instructor for LSVT Global, from whom she received lecture honorarium.

Non-financial: Carol Boliek has a preference for the LSVT® protocols and treatment techniques which will be discussed as a part of this course.

Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.

MedBridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact [email protected]. We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.

Accreditation Check:
Video Runtime: 62 Minutes; Learning Assessment Time: 29 Minutes

Understanding key principles that drive activity-dependent neuroplasticity may help guide clinicians in choosing the most appropriate treatment targets and mode of treatment delivery for children with pediatric motor speech disorders. This course will review key principles that are essential to driving activity-dependent neuroplasticity in pediatric populations. We will demonstrate how these principles can be integrated into a treatment protocol (Lee Silverman Voice Treatment [LSVT LOUD]) for pediatric clients, specifically children with dysarthria consequent to cerebral palsy (CP) or Down syndrome (DS). Research outcomes across acoustic, perceptual, and physiological levels will be discussed. Further, fast-phase and slow-phase neural changes in these children, as evidenced by structural and functional neuroimaging studies, will be explored. Finally, a review of tips for real-world implementation of intensive treatment programs for children dysarthria consequent to CP or DS will be discussed.

Meet Your Instructor

Cynthia M. Fox, PhD, CCC-SLP

Cynthia Fox, PhD, CCC-SLP, received her doctorate degree in speech and hearing sciences from the University of Arizona, Tucson. Her training focused in the areas of neuroscience and motor control. She is an expert on rehabilitation, neuroplasticity, and the role of exercise in the improvement of function consequent to neural injury and disease. She has…

Read full bio

Chapters & Learning Objectives

Download Learning Objectives

1. Practice Principles That Drive Activity-Dependent Neuroplasticity

This chapter will define key principles that drive activity-dependent neuroplasticity and discuss how these principles can be applied to speech treatment for children with dysarthria. A summary of published speech treatment studies for children with cerebral palsy and children with Down syndrome that incorporate these principles will be reviewed.

2. Key Concepts of the LSVT LOUD Protocol

The Lee Silverman Voice Treatment (LSVT LOUD) is an efficacious speech treatment developed for people with Parkinson’s disease with application to a range of dysarthria profiles, including those in childhood populations. An overview of the treatment protocol and rationale for applying it to children with dysarthria will be presented. The relationship of key LSVT LOUD treatment concepts and principles that drive activity-dependent neuroplasticity will be reviewed.

3. Behavioral and Neural Outcome Data in Children With Dysarthria Consequent to Cerebral Palsy and Down Syndrome

This chapter explores the current research on using LSVT LOUD for dysarthria in childhood populations. These studies will be explained through an expert interview with Dr. Carol Boliek, lead researcher for this work. Dr. Boliek will explain acoustic, perceptual, physiological, and neural imaging studies. She will discuss fast- and slow-phase neuroplasticity evidence and what that means for developing treatment protocols for these children.

4. Real-World Implementation of Intensive Speech Treatments (LSVT LOUD) for Pediatric Motor Speech Disorders

Effectively implementing intensive speech treatment programs for pediatric populations may require some paradigm shifts in clinical thinking and treatment delivery. A review of real-world considerations, including service delivery model options, how to stay the course when things get challenging, and the value of intrinsic reinforcement, will be covered.

Sign up to get free evidence-based articles, exclusive discounts, and insights from industry-leaders.